HIGHLANDS PHARMA LTD

🌱Startupactive
SC862927 · ltd · incorporated 2025-09-16
Investment thesis
Established operating company — standard diligence applies, no dominant angle.
Why interesting: Live, filing, normal profile.
Why risky: No standout signals in either direction.
🔒Estimated value
Upgrade to see
Turnover
not disclosed
Net worth
book net assets
Opportunity
71/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: SIC 46460
Sector: Wholesale & retail
Investor take
Pursue
Strong opportunity: active trading company with strong profile and acceptable with review structure.

Opportunity 71/100 (strong), bankability 65/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (58/100).

Data confidence

Overall: medium (55/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
No iXBRL financials extracted
0
Lenders & charges
Confirmed no charges registered
85
Directors & officers
2 officers (2 active, 2 linked, 2 with DOB)
90
Ownership & PSC
2 active PSC(s) of 2 total, 2 with control declared
90
Director network
3 connected companies via shared directors
54
Filing history
1 filing — limited history
30
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
71/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
60
Adequate — check latest filings for context.
Acquirability
55
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Recent activity

Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
0
filings
Counts from Companies House filing history.
Corporate timeline (4 events)Click to expand
  1. 2025-09-16
    🏢
    Company incorporated
    As HIGHLANDS PHARMA LTD
  2. 2025-09-16
    ADEN, Abdulkadir Mohamed appointed
    director
  3. 2025-09-16
    ANWAR, Amir appointed
    director
  4. 2025-09-16
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

63/100
High — earn-out structure required

Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.

FACTORS
  • +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
  • +Young company: Only 0.6 years old — management layer unlikely to be developed.

Succession & seller-readiness

36/100
Weak signal

Limited succession signal. Not a near-term off-market candidate.

SIGNALS
  • secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

2 active beneficial owners
NameSharesVoting rightsNature of controlNotified
Mr Abdulkadir Mohamed Aden
Individual · Dutch · DOB 08/1995 · age 31
2550%
25–50%board control25-50% shares · 25-50% voting · board control16/09/2025
Amir Anwar
Individual · British · DOB 02/1985 · age 41
2550%
25–50%board control25-50% shares · 25-50% voting · board control16/09/2025

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Wholesale & distribution · AB postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
KNC GROUNDWORKS LIMITED
SC451952 · est 2013 · no financials extracted
12y
KODAF LIMITED
SC768755 · est 2023 · no financials extracted
2y
LANGSTANE PRESS LIMITED
SC062202 · est 1977 · no financials extracted
49y
LEROCK LTD
SC752979 · est 2022 · no financials extracted
3y
LHR MARINE LIMITED
SC204492 · est 2000 · no financials extracted
26y
LOLI-LOSSIEN UK LTD
SC399089 · est 2011 · no financials extracted
14y
LONDON BABY LTD
SC833613 · est 2025 · no financials extracted
1y
LONG TECHNOLOGY LIMITED
SC105350 · est 1987 · no financials extracted
38y
LOSEFORLESS LIMITED
SC871989 · est 2025 · no financials extracted
LYDIE PRIVATE LTD
SC867728 · est 2025 · no financials extracted
M.AARIZ LIMITED
SC781988 · est 2023 · no financials extracted
2y
MACLEAN INTERNATIONAL GROUP LIMITED
SC065126 · est 1978 · no financials extracted
47y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2025-09-16
Jurisdictionscotland
Primary SIC46460 — SIC 46460

Registered office

14a St. Marys Place
Aberdeen
AB11 6HL
Scotland

Filing status

Accounts
Next due: 2027-06-16
Last made up to:
Confirmation statement
Next due: 2026-09-29
Last:

Officers (2 active · 0 resigned)

ADEN, Abdulkadir Mohamed
director · ~31y · appointed 2025-09-16
View their other companies + combined net worth →
Active
ANWAR, Amir
director · ~41y · appointed 2025-09-16
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (1 total)

incorporation-company
incorporation · NEWINC
2025-09-16